DDD Q1 2026 Earnings Significant EPS Beat Drives Stock Rally VTGN Q1 2026 Earnings NarrowerthanExpected Loss Amid Clinical Progress Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings EPS Misses Estimates as Biotech Focuses on Clinical Pipeline FRSX Q3 2021 Earnings EPS Surprises Positive Amid PreRevenue Development Stage VLRS Q1 2026 Earnings EPS Surpasses Estimates Despite Narrow Loss Urban One UONEK Q1 2026 Earnings Loss Per Share of 069 Amid Muted Market Reaction